Stability and equilibria of promiscuous aggregates in high protein milieus

被引:66
作者
Coan, Kristin E. D. [1 ]
Shoichet, Brian K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
关键词
D O I
10.1039/b616314a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
At micromolar concentrations, many molecules form aggregates in aqueous solution. In this form, they inhibit enzymes non-specifically leading to false positive "hits" in enzyme assays, especially when screened in high-throughput. This inhibition can be attenuated by bovine serum albumin (BSA); the mechanism of this effect is not understood. Here we present evidence that BSA, lysozyme, and trypsin prevent inhibition when incubated at milligram per millilitre concentrations with aggregates prior to the addition of the monitored enzyme. These solutions still contained aggregates by dynamic light scattering (DLS), suggesting that inhibition is prevented by saturating the aggregate, rather than disrupting it. For most combinations of aggregate and protein, inhibition was not reversed if the competing protein was added after the incubation of aggregates with the monitored enzyme. In the one exception where modest reversal was observed, DLS and flow cytometry indicated that the effect was due to the disruption of aggregates. These results suggest that aggregate-bound enzyme is not in dynamic equilibrium with free enzyme and that bound enzyme cannot be displaced by a competing protein. To further test this hypothesis, we incubated aggregate-bound enzyme with a specific, irreversible inhibitor and then disrupted the aggregates with detergent. Most enzyme activity was restored on aggregate disruption, indicating no modification by the irreversible inhibitor. These results suggest that enzyme is bound to aggregate so tightly as to prevent any noticeable dissociation and that furthermore, aggregates are stable at physiologically relevant concentrations of protein.
引用
收藏
页码:208 / 213
页数:6
相关论文
共 23 条
[1]   Reversible and covalent binding of drugs to human serum albumin: Methodological approaches and physiological relevance [J].
Bertucci, C ;
Domenici, E .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (15) :1463-1481
[2]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[3]   Avoiding physicochemical artefacts in early ADME-Tox experiments [J].
DeWitte, Robert S. .
DRUG DISCOVERY TODAY, 2006, 11 (17-18) :855-859
[4]   The extraordinary ligand binding properties of human serum albumin [J].
Fasano, M ;
Curry, S ;
Terreno, E ;
Galliano, M ;
Fanali, G ;
Narciso, P ;
Notari, S ;
Ascenzi, P .
IUBMB LIFE, 2005, 57 (12) :787-796
[5]   High-throughput assays for promiscuous inhibitors [J].
Feng, BY ;
Shelat, A ;
Doman, TN ;
Guy, RK ;
Shoichet, BK .
NATURE CHEMICAL BIOLOGY, 2005, 1 (03) :146-148
[6]   Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability [J].
Frenkel, YV ;
Clark, AD ;
Das, K ;
Wang, YH ;
Lewi, PJ ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1974-1983
[7]   Hit discovery and hit-to-lead approaches [J].
Keseru, Gyorgy M. ;
Makara, Gergely M. .
DRUG DISCOVERY TODAY, 2006, 11 (15-16) :741-748
[8]   Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor [J].
Lingameneni, R ;
Vysotskaya, TN ;
Duch, DS ;
Hemmings, HC .
FEBS LETTERS, 2000, 473 (02) :265-268
[9]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[10]   Detailed kinetic studies of an aggregating inhibitor; Inhibition of phosphomannomutase/phosphoglucomutase by Disperse Blue 56 [J].
Liu, HY ;
Wang, ZH ;
Regni, C ;
Zou, XQ ;
Tipton, PA .
BIOCHEMISTRY, 2004, 43 (27) :8662-8669